NASDAQ | ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index.
The Biotech Index includes common stocks and depositary receipts ofU. S. exchange-listed companies in the biotechnology industry.
Such companies may include medium-capitalization companies and foreign companies that are listed on aU. S. exchange.
It is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 15.76% |
GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 12.78% |
VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 10.27% |
ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 5.64% |
ARGX | argenx NV ADR | Healthcare | Biotechnology | 5.57% |
IQV | IQVIA Holdings Inc | Healthcare | Diagnostics & Research | 5.03% |
REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 5.02% |
INSM | Insmed Inc | Healthcare | Biotechnology | 3.67% |
ICLR | ICON PLC | Healthcare | Diagnostics & Research | 3.52% |
NTRA | Natera Inc | Healthcare | Diagnostics & Research | 3.44% |
BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.31% |
BGNE | BeiGene Ltd | Healthcare | Biotechnology | 3.19% |
ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 3.06% |
ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 2.91% |
BNTX | BioNTech SE | Healthcare | Biotechnology | 2.84% |
NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.75% |
MRNA | Moderna Inc | Healthcare | Biotechnology | 2.38% |
INCY | Incyte Corporation | Healthcare | Biotechnology | 2.15% |
TECH | Bio-Techne Corp | Healthcare | Biotechnology | 1.78% |
CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 1.71% |